Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. scores highest on Nitro (56) and lowest on Price (17). Its PosiPenta is 41.25 out of 100, around the middle of similar companies.
On the Penta Grid this week, Lexicon Pharmaceuticals, Inc. is Grid #493 of 837 in the Healthcare sector in United States, and Grid #2,754 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals, Inc. | 41.25 | 17 | 44 | 56 | 45 | 44 |
| Solid Biosciences Inc. | 38.31 | 32 | 31 | 48 | 49 | 31 |
| Attovia Therapeutics, Inc. | 36.71 | 0 | 28 | 38 | 62 | 55 |
| Wave Life Sciences, Inc. | 34.16 | 35 | 34 | 12 | 45 | 45 |
| Design Therapeutics, Inc. | 46.57 | 21 | 29 | 63 | 65 | 54 |
| Aura Biosciences, Inc. | 45.05 | 29 | 26 | 61 | 52 | 57 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -9.50 |
| P/B ratio | 3.88 |
EEarnings
| Trailing EPS | ₹-15.15 |
| Forward EPS | ₹-18.05 |
NNitro
| Price | 143.97 |
| 52-week high | 253.84 |
| 52-week low | 104.19 |
| Fall from 52-week high | 43.3% |
TTorque
| Return on equity (ROE) | -40.21% |
| Debt-to-equity | 0.34 |
AAnchor
| Beta (price swings) | 1.08 |
| Market cap | ₹6,405 Cr |
| Insider holding | 1.12% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Lexicon Pharmaceuticals, Inc.'s PosiPenta score?
Lexicon Pharmaceuticals, Inc.'s PosiPenta is 41.25 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Lexicon Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Lexicon Pharmaceuticals, Inc. is Grid #493 of 837 in the Healthcare sector in United States, and Grid #2,754 of 4,000 in United States.
Which PosiPenta pillar is strongest for Lexicon Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 56 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Lexicon Pharmaceuticals, Inc.?
Price (valuation), with a score of 17 out of 100: much weaker than most similar companies.
Has Lexicon Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.66 points, from 38.59 to 41.25.
PositoAI is for research and education only and is not investment advice.